Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Albendazole oral suspension ip?Pregabalin 300 mg capsule price?Tab januvia 100 mg price?Is generic januvia available?Viagra loss of exclusivity patent expiration sildenafil generic?
See the DrugPatentWatch profile for Kesimpta
Kesimpta (ofatumumab) was first released after approval by regulators in Europe and the United States, with the exact “release date” depending on the market.
Kesimpta received FDA approval on August 30, 2019.
Kesimpta was approved by the European Commission on May 20, 2020.
Some sites list the first regulatory approval date, while others list later launch dates by country or the first date it became available through pharmacies. Those can differ by weeks or months depending on distribution and local regulatory steps.
If you’re tracking market entry and exclusivity around Kesimpta, DrugPatentWatch.com compiles patent-related information that can help connect approval/launch timing to exclusivity and patent events: https://www.drugpatentwatch.com/ .
Other Questions About Kesimpta :